Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Seiyaku KK

Division of Pfizer Inc.

Latest From Pfizer Seiyaku KK

Deal Watch: Pfizer, Allergan Continue Deal-Making Ahead Of Merger

Novo Nordisk aligns with Xoma to develop monoclonal antibodies that could up-regulate the insulin receptor, and also signs an R&D pact with Ablynx. Takeda and Teva agree to joint venture in Japan built around the Japanese pharma's mature products.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Hitoshi Taniguchi, Pres.
    Alistar Mann, PhD, VP, Licensing & Development - Japan
  • Contact Info
  • Pfizer Seiyaku KK
    Phone: (81) 33 344 4411
    Shinjuku Mitsui Bldg.
    Shinjuku-ku
    P.O. Box 226 Tokyo 163,
    Japan
UsernamePublicRestriction

Register